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Abstract
Staphylococcus epidermidis is a leading nosocomial pathogen. In contrast to its more aggressive relative S. aureus, it causes
chronic rather than acute infections. In highly virulent S. aureus, phenol-soluble modulins (PSMs) contribute significantly to
immune evasion and aggressive virulence by their strong ability to lyse human neutrophils. Members of the PSM family are
also produced by S. epidermidis, but their role in immune evasion is not known. Notably, strong cytolytic capacity of S.
epidermidis PSMs would be at odds with the notion that S. epidermidis is a less aggressive pathogen than S. aureus,
prompting us to examine the biological activities of S. epidermidis PSMs. Surprisingly, we found that S. epidermidis has the
capacity to produce PSMd, a potent leukocyte toxin, representing the first potent cytolysin to be identified in that
pathogen. However, production of strongly cytolytic PSMs was low in S. epidermidis, explaining its low cytolytic potency.
Interestingly, the different approaches of S. epidermidis and S. aureus to causing human disease are thus reflected by the
adaptation of biological activities within one family of virulence determinants, the PSMs. Nevertheless, S. epidermidis has the
capacity to evade neutrophil killing, a phenomenon we found is partly mediated by resistance mechanisms to antimicrobial
peptides (AMPs), including the protease SepA, which degrades AMPs, and the AMP sensor/resistance regulator, Aps (GraRS).
These findings establish a significant function of SepA and Aps in S. epidermidis immune evasion and explain in part why S.
epidermidis may evade elimination by innate host defense despite the lack of cytolytic toxin expression. Our study shows
that the strategy of S. epidermidis to evade elimination by human neutrophils is characterized by a passive defense
approach and provides molecular evidence to support the notion that S. epidermidis is a less aggressive pathogen than S.
aureus.
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Introduction
Staphylococcus epidermidis colonizes the epithelial surfaces of every
human being. Furthermore, it is one of the most frequent causes of
nosocomial infections. In addition to the abundant prevalence of S.
epidermidis on the human skin, this high incidence is mainly due to
the exceptional capacity of S. epidermidis to stick to the surfaces of
indwelling medical devices during device insertion and form
multilayered agglomerations called biofilms [1,2].
During infection, S. epidermidis is exposed to human innate host
defenses, most notably professional phagocytes, among which
neutrophils or polymorphonuclear leukocytes (PMNs) play a
preeminent role [3]. While the biofilm mode of growth is believed
to be broadly protective against host defenses [1,4], we lack
information on specific molecules of S. epidermidis that provide
resistance to host defense mechanisms. The only S. epidermidis
molecules known to facilitate evasion of killing by neutrophils are
the extracellular polymers poly-N-acetylglucosamine (PNAG, or
PIA, polysaccharide intercellular adhesin) and poly-c-glutamic
acid (PGA), which inhibit uptake by neutrophils (phagocytosis)
[5,6]. This is in contrast to S. aureus, a more pathogenic relative of
S. epidermidis, which produces a series of proteins and enzymes
dedicated to evade innate and adaptive host defense [7,8].
Immune evasion of S. aureus is due in part to cytolytic toxins,
such as a-toxin, c-toxin, or Panton-Valentine leukocidin, which
are proinflammatory and have potential to lyse neutrophils and
other leukocytes [9]. In addition, we recently identified a new class
of S. aureus cytolytic toxins, the phenol-soluble modulins (PSMs).
Several PSM peptides have high capacity to attract, stimulate and
lyse human neutrophils, and are significant contributors to
pathogenesis of S. aureus bacteremia and skin infection [10].
PSMa3, in particular, is the most cytolytic S. aureus PSM and
encoded together with three other PSMs in the psma operon of S.
aureus. High expression of peptides encoded in the psma operon is
mainly responsible for the pronounced potential of hyper-virulent
community-associated methicillin-resistant S. aureus (CA-MRSA)
PLoS Pathogens | www.plospathogens.org 1 October 2010 | Volume 6 | Issue 10 | e1001133strains to lyse human neutrophils [10], underpinning the
importance of PSMs for neutrophil lysis. In contrast to S. aureus,
toxins that lyse human leukocytes or other cell types have not been
described in S. epidermidis.
PSMs are characterized by common physico-chemical proper-
ties rather than similarity at the amino acid sequence level (Fig. 1).
Identification of PSMs thus requires isolation and characterization
by means such as mass spectrometry and Edman degradation.
Using these methods, six members of the PSM family have been
identified in S. epidermidis (Fig. 1) [11,12,13,14], but their biological
significance is largely undefined. This is in part due to the fact that
in earlier studies, a partially purified extract from S. epidermidis
containing PSMs was used to measure PSM activities
[12,15,16,17]. Therefore, it is possible that proinflammatory
activities previously attributed to S. epidermidis PSMs were caused
by contaminants such as lipopeptides, particularly as similar
impurities have frequently led to the misinterpretation of
stimulatory effects on innate immune system mechanisms in the
past [18]. This emphasizes the need to analyze pure peptides, but
pure S. epidermidis PSMs and especially cytolytic potencies of S.
epidermidis PSMs have never been investigated.
After phagocytosis, neutrophils kill bacteria with reactive
oxygen species and non-oxygen-dependent processes [19]. Among
the latter, antimicrobial peptides (AMPs) such as defensins and
cathelicidins are believed to play a crucial role [20]. We have
previously found that the secreted S. epidermidis protease SepA has
considerable capacity to eliminate AMPs by proteolysis [21].
Furthermore, we identified the first Gram-positive AMP sensing
system in S. epidermidis, apsRSX [22]. This system, which has also
been named graRSX in S. aureus [23,24], regulates a series of AMP
resistance mechanisms, including Dlt-dependent D-alanylation of
teichoic acids [25], MprF-dependent lysinylation of phospholipids
[26], and an AMP exporter called VraFG [24]. However, it is not
known whether Aps or SepA confer resistance to killing by
neutrophils.
In the present study, we examined the role of S. epidermidis PSMs
in immune evasion, in particular by determining whether S.
epidermidis PSMs are cytolytic toward human neutrophils. Further-
more, we analyzed whether the sepA and apsRSX loci facilitate
survival during phagocytic interaction with neutrophils. Our study
provides a better understanding of how S. epidermidis evades killing
by human leukocytes in the susceptible host. Notably, we identified
the first potent S. epidermidis cytolysin, PSMd, a member of the a-
type PSM family. However, despite the capacity to produce a
potent cytolysin, S. epidermidis culture supernatants had little or no
capacity to lyse neutrophils. In contrast, we show that the SepA
protease and the Aps AMP sensor significantly promote resistance
of S. epidermidis to killing by neutrophils. These findings provide
molecular evidence to support the notion that S. epidermidis,i n
strong contrast to virulent S. aureus, has a defensive rather than
aggressive approach to infection and immune evasion.
Results
Cytolytic activity of S. epidermidis culture filtrates
To evaluate the relative potency of S. epidermidis to kill human
neutrophils, we compared culture filtrates of different S. epidermidis
strains with those of S. aureus LAC, a CA-MRSA strain with
demonstrated high capacity to lyse neutrophils [10,27]. We
investigated four S. epidermidis strains that have been most
frequently used in S. epidermidis pathogenesis studies: 1457, O47,
ATCC12228, and RP62A. ATCC12228 and RP62A represent
the two S. epidermidis strains for which genome sequence data are
Figure 1. S. epidermidis and S. aureus PSMs. All known S. aureus (S. a.) and S. epidermidis (S. e.) PSMs were aligned by a sequence comparison
program (Vector NTI). Similarity on the amino acid level is depicted as a tree on the left. Aligned amino acid sequences are shown at the right, with
conserved amino acids shown in blue. All PSMs contain a region with pronounced amphipathy and a-helicity, boxed in yellow.
doi:10.1371/journal.ppat.1001133.g001
Author Summary
Staphylococcus epidermidis frequently causes chronic
infections, indicating pronounced capacity to evade host
defenses. However, S. epidermidis is in general much less
aggressive than its close relative, S. aureus. Here we
identify molecular underpinnings of that discrepancy by
showing that S. epidermidis immune evasion mechanisms
are limited to those involving molecules that protect
against or eliminate antimicrobial agents secreted by
white blood cells, while immune evasion mechanisms of
virulent S. aureus include the production of destructive
toxins. This is especially noteworthy, because we demon-
strate here for the first time that S. epidermidis has the
capacity to produce a toxin with great potential to destroy
white blood cells, but keeps its production at a very
limited level. Thus, our study shows that two closely
related human pathogens have adapted specific molecular
mechanisms to evade host defenses, reflecting the unique
approach used by each to cause human disease.
Staphylococcus epidermidis and Neutrophils
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strain 1457, as the agr regulatory system is known to strictly
regulate PSM production [10,29,30].
Culture filtrates of all four S. epidermidis strains showed
significantly reduced lysis of human neutrophils compared to S.
aureus LAC (Fig. 2), indicating that as a species S. epidermidis has low
capacity to lyse neutrophils. Some low-level cytolysis was detected
in culture filtrates from strain 1457, but not strains RP62A and
ATCC12228. Furthermore, cytolytic capacity of culture filtrates
was completely abolished in an agr deletion mutant of strain 1457
and in the natural agr mutant strain O47 (Fig. 2), in accordance
with a potential function of the agr-regulated PSMs of S. epidermidis
in neutrophil lysis.
Analysis of PSM secondary structure
In vitro studies using S. aureus and S. epidermidis c-toxins and S.
epidermidis PSMd indicated that PSMs lead to perturbation of
synthetic membrane vesicles and likely work by pore formation in
the absence of a specific receptor [31,32,33]. Presumably, the
capacity of PSMs to lyse cells is thus dependent on their physico-
chemical features, namely the ability to form amphipathic a-
helices, a characteristic property of pore-forming peptides.
To evaluate whether S. epidermidis PSMs form amphipathic a-
helices, we determined secondary structures of PSM peptides using
circular dichroism (Fig. 3A, B). These experiments demonstrated
that all S. epidermidis PSMs are predominantly a-helical. When
PSM sequences were arranged in a-helical wheels, all predicted a-
helices showed a distinct hydrophilic opposed to a hydrophobic
side, which is characteristic for amphipathic a-helices (shown as an
example for PSMb1 in Fig. 3C). These findings indicate that S.
epidermidis PSMs have the basic structural requirements for
membrane perturbation and pore formation.
Capacity of S. epidermidis PSMs to lyse neutrophils
To analyze whether S. epidermidis PSMs lyse neutrophils, we
incubated human neutrophils with pure, synthetic S. epidermidis
PSMs. Remarkably, one S. epidermidis PSM, PSMd, caused high
levels of neutrophil lysis, to an extent comparable to that of the
potent S. aureus PSMa3 (Fig. 4A). In contrast, S. epidermidis d-toxin,
PSMa, and PSMe showed only very limited cytolytic capacity.
The b-type PSMs were non-cytolytic toward neutrophils, in
keeping with findings achieved for the b-type PSMs of S. aureus
[10]. These differences indicate that while the formation of
amphipathic a-helices is a likely prerequisite for membrane
perturbation, further yet unknown structural features determine
the degree of cytolytic activity in PSMs. This notion is also
supported by our observation that the degree of a-helicity (Fig. 3A)
did not correlate with the cytolytic potential of PSMs (Fig. 4A). Of
note, PSMd to our knowledge represents the first potent cytolysin
of S. epidermidis to be identified. Remarkably, PSMd is less closely
related to S. aureus PSMa3 by amino acid sequence comparison
than are PSMa1, PSMa2, and S. epidermidis PSMe (Fig. 1),
underlining the notion that cytolytic properties of PSMs are
determined by secondary rather than primary structure.
The strong potency of PSMd to lyse human neutrophils was
confirmed by expression of PSMd in an agr-negative S. epidermidis
strain that lacks production of PSMs (Fig. 4B). Induction of PSMd
production resulted in a significant increase in the capacity of
culture filtrates from the agr-negative strain to lyse human
neutrophils (p=0.0015, agr pTXpsmd versus agr pTX16 control).
As we have observed previously [10,34], plasmid-based expression
of PSM peptides often does not result in concentrations of PSMs as
high as those found in wild-type culture filtrates, which also was
the case for PSMd. However, the degree of neutrophil lysis exerted
by culture filtrates of the PSMd expression strain (20.1% of that by
the wild-type) corresponded very well to PSMd expression (18.6%
of that in the wild-type) (Fig. 4B), highlighting the major
contribution PSMd has to the overall cytolytic capacity of S.
epidermidis.
Hemolytic activity of S. epidermidis PSMs
We showed previously that S. aureus PSMs also lyse cells other
than neutrophils, such as monocytes or erythrocytes [10]. To
analyze whether lysis of erythrocytes by synthetic PSMs and
staphylococcal culture filtrates follows the same pattern as
observed using human neutrophils, we tested hemolysis. Results
were in very good accordance with those achieved with human
neutrophils, inasmuch as only PSMd showed strong hemolytic
activity at a level comparable to that exerted by S. aureus PSMa3
(Fig. 5A). Similarly, culture filtrates of S. epidermidis strains were
much less hemolytic than those of S. aureus LAC, with that of S.
epidermidis 1457 causing slightly higher hemolysis than culture
filtrates from the other S. epidermidis strains (Fig. 5B), in keeping
with the neutrophil lysis findings.
Production characteristics of PSMs in S. epidermidis
The finding that S. epidermidis PSMd has considerable cytolytic
activity at first appeared to contradict the low cytolytic activity of
S. epidermidis culture filtrates. Indeed, it was reminiscent of the
situation in S. aureus, in which the cytolytic potential is also mostly
determined by one strongly cytolytic PSM peptide, PSMa3 [10].
However, potential differences in PSM production are not
considered in this comparison. Therefore, we next measured
PSM production patterns in S. epidermidis strains compared to those
in S. aureus. We found considerable differences in the relative PSM
production patterns between S. aureus and S. epidermidis, while
patterns among the different S. epidermidis strains were similar
Figure 2. Neutrophil lysis by S. epidermidis culture filtrates.
Neutrophil (PMN) lysis by undiluted S. epidermidis 18-h culture filtrates
was determined by measuring release of LDH (incubation time, 1 h).
Culture filtrate from S. aureus LAC (18-h culture) was used as a
comparison.
doi:10.1371/journal.ppat.1001133.g002
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dichroism (CD) measurement. (A), molar ellipticity curves; (B) analysis of secondary structure using 3 different algorithms. (C) All PSM peptides have an
amphipathic a-helix that encompasses most of the peptide for the shorter a-type and the C-terminal part of the b-type PSMs (shown as example for
PSMb1b ya-helical wheel presentation, http://heliquest.ipmc.cnrs.fr).
doi:10.1371/journal.ppat.1001133.g003
Figure 4. Neutrophil lysis by S. epidermidis PSM peptides and culture filtrates of PSMd-expression strains. (A) Neutrophil (PMN) lysis by
synthetic, N-formylated PSM peptides at 10 mg/ml was determined by measuring release of LDH (incubation time, 1 h). PSMa3( S. aureus) was used as
a comparison at the same concentration. (B) Neutrophil lysis using supernatants (18-h cultures) of a PSMd-over-expressing agr-negative (lacking
intrinsic PSM production) and corresponding control strains (incubation time, 6 h). pTXpsmd, pTX construct expressing PSMd; pTX16, control plasmid.
Strains were grown in TSB with 0.5% xylose and 12.5 mg/ml tetracycline. **, p,0.01, paired t-tests. Blue bars, PSMd concentration in the culture
filtrates relative to that in the 1457 wild-type (set to 100%).
doi:10.1371/journal.ppat.1001133.g004
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analyzed a large S. epidermidis strain collection. Results were similar
in all strains, except for strains that completely lacked PSM
production (data not shown). These PSM-negative strains are
likely functionally agr-negative, owing to frequently occurring
mutations in the agr system [35], which includes the agr-negative
strain O47 [36].
The most noticeable difference between S. epidermidis and S.
aureus was strongly reduced production of a-type PSMs, except d-
toxin, in S. epidermidis. In contrast, the non-cytolytic b-type PSMs
represented almost half of the total PSM peptide produced in S.
epidermidis, whereas concentrations of b-type PSMs were extremely
low in S. aureus. Furthermore, the difference between the
production levels of the most cytolytic PSMs in the two species,
PSMa3 and PSMd (,5:1), correlated with the degree of overall
neutrophil lysis (,5:1, S. aureus LAC to S. epidermidis 1457),
underlining that these most potent PSMs predominantly deter-
mine cytolytic capacity. Moreover, the notion that any cytolytic
activity of S. epidermidis is largely determined by production of
PSMd is in accordance with the observed low production of PSMd
and overall low cytolytic activity of all tested S. epidermidis strains.
Thus, although S. epidermidis has the capacity to secrete a potent
cytolytic toxin, PSMd, it limits hemolysis or lysis of neutrophils by
keeping production of PSMd at a low level.
Deformylation of N-formyl methionine in PSMs
The N-formyl methionine group present at the N-terminus of
newly synthesized bacterial proteins is recognized by immune cells
as a pathogen-associated molecular pattern (PAMP) [37].
Removal of the N-formyl group by bacterial peptide deformylase
thus serves to evade recognition by human innate host defense. N-
formylated bacterial proteins commonly are not exported with N-
formyl-methionine, as their signal peptides are removed during
export. In contrast, PSMs are secreted as the unaltered translation
product by a yet unidentified mechanism and thus always carry N-
formyl methionine, likely representing a very considerable portion
of N-formylated peptides released by staphylococci [10]. In S.
aureus LAC culture filtrates, about one-half of the total PSM
peptide was N-deformylated, which is in good accordance with a
previous report on d-toxin deformylation in another S. aureus strain
[38]. In remarkable contrast, no significant deformylation was
detected in S. epidermidis PSMs (Fig. 6). Thus, despite the presence
Figure 5. Hemolysis by S. epidermidis culture filtrates and PSM peptides. Hemolysis was determined by assays using sheep blood. (A)
Hemolysis by synthetic, N-formylated PSMs of S. epidermidis. Negative control, DPBS. (B) Hemolysis by S. epidermidis culture filtrates (undiluted) and S.
aureus LAC culture filtrate as comparison. All culture filtrates were from cultures grown for 18 h. Negative control, DPBS; positive control, 1% (v/v)
Triton-X100 in DPBS.
doi:10.1371/journal.ppat.1001133.g005
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to the S. aureus enzyme (80% identity on the amino acid level),
proteins are not N-deformylated in S. epidermidis as efficiently as in
S. aureus.
Proinflammatory capacity of S. epidermidis culture
filtrates and PSMs
In addition to causing cytolysis, PSMs of S. aureus are known to
stimulate neutrophil and monocyte chemotaxis, activate neutro-
phils, and elicit release of the chemokine IL-8 [10]. These
proinflammatory capacities of PSMs indicate that the innate
immune system recognizes PSMs as PAMPs, which as we recently
discovered is achieved by recognition of PSMs by the FPR2/ALX
receptor [39]. To determine S. epidermidis proinflammatory
capacities, we analyzed stimulation of IL-8 release (Fig. 7A). IL-
8 is an important chemokine that causes recruitment of
neutrophils to the site of infection [40]. PSMd had very strong
capacity to stimulate release of IL-8; but overall, stimulation of IL-
8 release did not correlate with the cytolytic capacities of PSMs.
Notably, all S. epidermidis PSMs to some degree stimulated release
of IL-8 despite the lack of cytolytic capacity in several of them.
Accordingly, capacities of S. epidermidis culture filtrates to stimulate
IL-8 release were in the same range as those of S. aureus LAC
(Fig. 7B). Finally, stimulation of IL-8 release was significantly lower
for the S. epidermidis agr mutant of strain 1457 compared to the
corresponding isogenic wild-type strain, and very low for the
natural agr mutant strain O47, in keeping with strict regulation of
PSMs by agr [30]. Thus, while the different PSM production
pattern in S. epidermidis correlates with considerably reduced
neutrophil lysis compared to S. aureus, S. epidermidis PSMs still
appear to be recognized efficiently as PAMPs. These results
suggest that PSM cytolytic and proinflammatory capacities are
dependent on distinct interactions with host cells.
SepA protease and Aps AMP sensor/resistance regulator
of S. epidermidis promote resistance to killing by
neutrophils
Our results suggest that S. epidermidis does not use PSM cytolytic
activity to a significant extent to evade killing by human
neutrophils. However, the capacity of S. epidermidis to cause
chronic infections indicates that S. epidermidis has means to inhibit
elimination by human professional phagocytes. As an alternative
strategy to evade killing by human neutrophils, bacteria may
secrete enzymes to destroy – or use mechanisms to decrease – the
antimicrobial efficiency of neutrophil bactericidal agents [3].
Among those agents, antimicrobial proteins and peptides likely
play an important role in the killing of ingested bacteria [41]. We
previously showed that the secreted S. epidermidis protease SepA has
strong capacity to destroy human AMPs [21]. In addition, we
identified a system that we named Aps (for antimicrobial peptide
sensor) that senses the presence of human AMPs and coordinates a
series of AMP resistance mechanisms in S. epidermidis [22] and S.
aureus [24]. While the mechanistic function of these loci is thus well
understood, evidence for a significant role of Aps and SepA in
Figure 6. PSM concentrations in S. epidermidis culture filtrates. PSM concentrations in 18-h S. epidermidis and S. aureus LAC culture filtrates
were determined by HPLC/MS. Peaks corresponding to N-formylated and deformylated PSM versions were measured separately and the percentage
of deformylated peptides is shown as checkered bars. No PSMs were detected in the natural and constructed agr mutants (O47, 1457 agr). Relative
PSM composition (a-type, d-toxin, b-type) is shown at the right for S. aureus LAC and S. epidermidis 1457. Relative compositions were similar to that of
1457 in the other S. epidermidis strains (except in agr-negative O47 and 1457 agr).
doi:10.1371/journal.ppat.1001133.g006
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investigated whether S. epidermidis SepA and S. epidermidis and S.
aureus Aps contribute to survival after uptake by human
neutrophils. Isogenic sepA and aps mutants of S. epidermidis 1457
had significantly reduced ability to survive after phagocytic
interaction with human neutrophils compared to the wild-type
strain (Fig. 8), providing evidence for an important function of the
aps and sepA loci in S. epidermidis immune evasion. Similarly, the
Aps system had a significant impact on the survival of the S. aureus
CA-MRSA strain MW2 after phagocytosis. Of note, this effect was
comparable to that of the psma locus, which encodes the most
important cytolytic PSM peptides of S. aureus (Fig. 8B,C). These
findings indicate that the Aps AMP-sensing system has an
important immune evasion task in both species, while only S.
aureus makes additional use of cytolytic toxins, such as PSMs, to
evade killing by human neutrophils. This discrepancy is reflected
by the higher capacity of S. aureus to survive interaction with
human neutrophils compared to S. epidermidis (Fig. 8).
Discussion
As a commensal organism living on the human skin, S.
epidermidis commonly has a benign relationship with its host and
may even contribute to reducing inflammatory responses [2,42].
However, S. epidermidis may cause infection after breach of the
epithelial barrier and entry into the bloodstream, such as through
contamination of indwelling medical devices during surgery.
Although most S. epidermidis infections are only moderately severe
and usually chronic, their sheer frequency poses a considerable
problem, predominantly in the hospital setting [2,43]. Despite the
immense importance of S. epidermidis infections for public health,
the interaction of S. epidermidis with host defenses is poorly
understood. In particular, it has not been investigated in detail if
and how S. epidermidis resists killing by human neutrophils, which
are largely responsible for elimination of invading bacteria.
Therefore, we here investigated the interaction of S. epidermidis
with neutrophils. As direct lysis of neutrophils by bacterial
cytolysins is an efficient means to evade killing, we focused our
investigation on PSMs as the only S. epidermidis gene products with
potential cytolytic activity [14,28].
A major finding of our study was the identification of PSMd as
the first S. epidermidis toxin with significant cytolytic capacity.
However, despite the cytolytic potential of PSMd, culture filtrates
of S. epidermidis strains had very low capacity to lyse human
neutrophils. Importantly, according to our findings this phenotypic
difference between virulent S. aureus and S. epidermidis is caused at
least in part by a pattern of PSM production in S. epidermidis that is
shifted, compared to S. aureus, to PSMs with lower cytolytic
potential. Thus, PSMs in S. epidermidis do not contribute
significantly to neutrophil lysis, in contrast to many virulent
strains of S. aureus. Likely, PSMs fulfill other roles in S. epidermidis
that are yet poorly understood, such as in biofilm development
[44] or bacterial interference [33]. The production of PSMs that
are not potent cytotoxins would thus ascertain that S. epidermidis
may cause chronic, biofilm-associated infection without promoting
acute, purulent inflammation. This is in keeping with a general
strategy of S. epidermidis to reside inside the human host in a state of
‘‘hiding’’ from the immune system. Potentially, a similar strategy is
Figure 7. IL-8 release by neutrophils stimulated by S. epidermi-
dis PSMs and culture filtrates. PMNs were incubated with synthetic,
N-formylated PSMs (10 mg/ml) (A) or 18-h culture filtrates (diluted 1:100)
(B) and release of the cytokine IL-8 was measured by ELISA (for culture
filtrates with further 1:2 dilution). LPS, lipopolysaccharide, 10 ng/ml;
LTA, S. aureus lipoteichoic acid, 1 mg/ml.
doi:10.1371/journal.ppat.1001133.g007
Figure 8. Survival of aps and sepA deletion mutants in human
neutrophils. Survival of S. epidermidis 1457 and S. aureus MW2 wild-
type (wt) and isogenic gene deletion mutants was determined after
phagocytic uptake by counting of colony forming units after 60 min
incubation. Bacterial cells used for the experiment were harvested at
similar points in growth at an OD600 nm of ,1.5. ***, p,0.001;
**, p,0.01 versus the corresponding wild-type sample (1-way ANOVA,
Dunnett’s post test). Error bars represent SEM.
doi:10.1371/journal.ppat.1001133.g008
Staphylococcus epidermidis and Neutrophils
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strains, which are less virulent, cause chronic rather than acute
infection, and produce less cytolytic toxins, such as PSMs.
In addition, our study revealed significant contributions of the
SepA protease and the Aps AMP sensor/regulator to promoting S.
epidermidis survival in human neutrophils. Thus, S. epidermidis is able
to combat important mechanisms that neutrophils use to kill
bacteria after phagocytosis. However, together with previous
findings on S. aureus survival in human neutrophils [27], our data
indicate that these mechanisms are not as efficient as leukocyte
toxins, underlining the notion that S. epidermidis is in general less
virulent than S. aureus as a result of lower capacity to survive after
neutrophil phagocytosis. This is in accordance with a very early
study that showed increased survival of ‘‘pathogenic’’ (i.e.
coagulase-positive) versus ‘‘non-pathogenic’’ (i.e. coagulase-nega-
tive) staphylococci in human leukocytes [45]. Nevertheless, our
study shows that - combined with mechanisms preventing
neutrophil phagocytosis, such as surface exopolymers and biofilm
formation - S. epidermidis has a multi-faceted program providing
resistance to neutrophil killing, explaining at least in part the
capacity of S. epidermidis to cause long-lasting infection in the
susceptible host. Moreover, as we have shown previously that
SepA production is under control of Agr and SarA [21], our
findings confirm the notion that global regulatory systems play key
roles in S. epidermidis immune evasion [46], and are reminiscent of
similar functions of Agr and SarA in S. aureus [47,48]. Finally, the
observed significant effects of AMP resistance mechanisms on
survival in neutrophils underline the importance of non-oxygen-
dependent antimicrobial processes of the host.
Collectively, our findings indicate that the molecular mecha-
nisms that S. epidermidis uses to evade elimination by innate host
defense reflect a passive defense strategy rather than use of
aggressive toxins and point to a different major role of PSM
production in S. epidermidis compared to S. aureus.
Materials and Methods
Ethics statement
Human neutrophils were obtained from healthy volunteers in
accordance with a protocol approved by the Institutional Review
Board for Human Subjects, NIAID. Informed written consent was
received from human volunteers.
Bacterial strains and growth conditions
Bacterial strains used in this study were S. epidermidis strains 1457
[49], RP62A [14,50], ATCC12228 [28], O47 [51], isogenic agr,
sepA, and apsS deletion mutants of strain 1457 [21,22,52], S. aureus
strains LAC (pulsed-field type USA300) [53] and MW2 (pulsed-
field type USA400) [54] and the isogenic aps and psma mutants of
strain MW2 [24]. LAC and MW2 are virulent community-
associated MRSA strains. Strains were grown in tryptic soy broth
(TSB). The psmd over-expression plasmid pTXpsmd [34] was
transformed in S. epidermidis agr. Expression of PSMd by this
construct is achieved by adding xylose, which acts on a xylose-
inducible promoter in front of the cloned psmd gene [55].
Peptide synthesis
PSM peptides were synthesized by commercial vendors with an
N-terminal formyl methionine residue in each peptide. Peptide
sequence fidelity was determined by the Peptide Synthesis Unit of
the NIAID. Peptide stock solutions were prepared at 10 mg/ml
in DMSO (dimethylsulfoxide); further dilutions were made in
water.
Neutrophil preparation and lysis assays
PMNs were isolated from venous blood of healthy volunteers as
described [56]. Lysis of PMNs by synthetic PSMs or clarified S.
aureus or S. epidermidis culture media was determined essentially as
described [27,56]. Synthetic PSMs were added to wells of a 96-
well tissue culture plate containing 10
6 PMNs and plates were
incubated at 37uC. After 1 h, PMN lysis was determined by
release of lactate dehydrogenase (LDH) (Cytotoxicity Detection
Kit, Roche Applied Sciences). Alternatively, S. aureus and S.
epidermidis strains were cultured for 18 h at 37uC in 50 ml TSB (+/
2 0.5% xylose) with shaking using a 100 ml flask. Bacteria were
removed by centrifugation and culture media were sterilized by
filtration and stored at 280uC in aliquots until used. Culture
medium was mixed with human PMNs (10
6) and tested for its
ability to cause PMN lysis using incubation times of up to 6 h, as
indicated.
Resistance of S. epidermidis and S. aureus to killing by
human neutrophils
For measurement of S. epidermidis/S. aureus survival after
phagocytic interaction with neutrophils, PMNs (10
6) in RPMI
were combined with ,10
7 RPMI-washed bacteria from mid-
logarithmic growth phase in 96-well flat-bottom microtiter plates.
Plates were centrifuged at 3806g for 8 min to synchronize
phagocytosis and incubated at 37uC for up to 1 h. At the desired
time points, 22 ml of 1% saponin was added, well contents were
mixed, and the plates were incubated on ice for 15 min. Surviving
bacteria were enumerated. % survival was calculated by
comparing the numbers of surviving bacteria to those at t=0.
Cytokine production assay
After isolation and washing, neutrophils were resuspended in
RPMI 1640 medium (Sigma) supplemented with 10% human
serum, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml
streptomycin, 2 mM sodium pyruvate, and 10 mM HEPES. Cells
were distributed to a 96-well culture plate at 200 ml and 5610
5
cells per well. Synthetic PSMs or filtered bacterial culture
supernatants were diluted in fresh culture medium (1:100) and
added to the plate at 100 ml/well. Plates were incubated at 37uCi n
a 5.5% CO2 incubator for 5 h. Then, the plate was centrifuged at
1500 rpm for 10 min, and supernatant was harvested from each
well. IL-8 was measured in the culture supernatants with
commercial ELISA assay kits (R&D systems) according to the
manufacturer’s instructions. Diluted culture filtrates were further
diluted 1:2 for the ELISA.
Hemolysis assay
Hemolytic activities of culture filtrates from 18-h cultures of S.
epidermidis strains or synthetic PSM peptides at different concen-
trations were determined by incubating samples with sheep red
blood cells (2% v/v in Dulbecco’s phosphate-buffered saline,
DPBS) for 1 h at 37uC as previously described [10]. Assays were
performed in triplicate.
Analysis of PSM production
RP-HPLC/ESI-MS was performed on an Agilent 1100
chromatography system coupled to a Trap SL mass spectrometer
using a Zorbax SB-C8 2.3630 mm column as described [30].
Quantification was based on extracted ion chromatograms using
the most abundant peaks of the electrospray ion mass spectra of
the respective PSM peptides, with calibration using synthetic
peptides, as described [30].
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The structures of synthetic PSM peptides were analyzed by CD
spectroscopyona Jasco spectropolarimeter model J-720instrument.
Solutions of PSM peptides, each at 1.0 mg/ml, were prepared in
50% trifluoroethanol. Measurements were performed in triplicate
and the resulting scans were averaged, smoothed, and the buffer
signal was subtracted. Computation of relative fraction of helix,
sheet, turn, and unordered structure, using 3 different algorithms,
was performed according to Sreerama and Woody [57].
Statistical analyses
Statistical analyses were performed with Graph Pad Prism 5
software using t-tests or 1-way ANOVA with Bonferroni or
Dunnett post tests, as appropriate.
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